A detailed history of Met Life Investment Management, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Met Life Investment Management, LLC holds 46,494 shares of NKTR stock, worth $60,442. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,494
Holding current value
$60,442
% of portfolio
0.0%

Shares

60 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.9 - $1.83 $41,844 - $85,084
46,494 New
46,494 $57,000
Q1 2023

May 09, 2024

BUY
$0.64 - $3.15 $38,942 - $191,671
60,848 New
60,848 $42.8 Million
Q1 2023

May 15, 2023

SELL
$0.64 - $3.15 $21,885 - $107,717
-34,196 Reduced 35.98%
60,848 $42,000
Q4 2022

Jun 14, 2023

BUY
$2.03 - $4.28 $69,417 - $146,358
34,196 Added 56.2%
95,044 $214,000
Q3 2022

Jun 14, 2023

BUY
$3.04 - $5.14 $103,955 - $175,767
34,196 Added 56.2%
95,044 $304,000
Q2 2022

May 10, 2024

BUY
$3.17 - $6.17 $289,906 - $564,265
91,453 Added 2546.73%
95,044 $361,000
Q2 2022

Jun 20, 2023

BUY
$3.17 - $6.17 $108,401 - $210,989
34,196 Added 56.2%
95,044 $361,000
Q2 2022

Mar 22, 2023

BUY
$3.17 - $6.17 $289,906 - $564,265
91,453 Added 2546.73%
95,044 $361,000
Q2 2022

Aug 11, 2022

BUY
$3.17 - $6.17 $289,906 - $564,265
91,453 Added 2546.73%
95,044 $361,000
Q1 2022

May 10, 2024

BUY
$4.16 - $13.72 $14,938 - $49,268
3,591 New
3,591 $19,000
Q1 2022

Jun 20, 2023

SELL
$4.16 - $13.72 $238,189 - $785,566
-57,257 Reduced 94.1%
3,591 $19,000
Q1 2022

Mar 22, 2023

SELL
$4.16 - $13.72 $367,065 - $1.21 Million
-88,237 Reduced 96.09%
3,591 $19,000
Q1 2022

May 12, 2022

BUY
$4.16 - $13.72 $14,938 - $49,268
3,591 New
3,591 $19,000
Q4 2021

Feb 15, 2022

SELL
$10.83 - $18.41 $994,497 - $1.69 Million
-91,828 Closed
0 $0
Q3 2021

May 17, 2024

SELL
$13.07 - $18.84 $36,543 - $52,676
-2,796 Reduced 3.07%
88,299 $1.59 Million
Q3 2021

Jun 21, 2023

BUY
$13.07 - $18.84 $358,784 - $517,176
27,451 Added 45.11%
88,299 $1.59 Million
Q3 2021

Mar 22, 2023

BUY
$13.07 - $18.84 $9,580 - $13,809
733 Added 0.8%
91,828 $1.65 Million
Q3 2021

Nov 15, 2021

BUY
$13.07 - $18.84 $9,580 - $13,809
733 Added 0.8%
91,828 $1.65 Million
Q2 2021

May 17, 2024

SELL
$16.52 - $20.4 $49,708 - $61,383
-3,009 Reduced 3.2%
91,095 $1.56 Million
Q2 2021

Jun 21, 2023

BUY
$16.52 - $20.4 $499,680 - $617,038
30,247 Added 49.71%
91,095 $1.56 Million
Q2 2021

Mar 22, 2023

SELL
$16.52 - $20.4 $107,677 - $132,967
-6,518 Reduced 6.68%
91,095 $1.56 Million
Q2 2021

Aug 16, 2021

SELL
$16.52 - $20.4 $107,677 - $132,967
-6,518 Reduced 6.68%
91,095 $1.56 Million
Q1 2021

May 17, 2024

BUY
$16.56 - $25.46 $1.56 Million - $2.4 Million
94,104 New
94,104 $1.88 Million
Q1 2021

Jun 26, 2023

BUY
$16.56 - $25.46 $550,719 - $846,697
33,256 Added 54.65%
94,104 $1.88 Billion
Q1 2021

Mar 22, 2023

SELL
$16.56 - $25.46 $9,207 - $14,155
-556 Reduced 0.57%
97,613 $1.95 Million
Q1 2021

May 14, 2021

SELL
$16.56 - $25.46 $9,207 - $14,155
-556 Reduced 0.57%
97,613 $1.95 Million
Q4 2020

May 24, 2024

SELL
$15.77 - $19.03 $67,148 - $81,029
-4,258 Reduced 4.16%
98,169 $1.67 Million
Q4 2020

Jun 22, 2023

BUY
$15.77 - $19.03 $588,552 - $710,218
37,321 Added 61.33%
98,169 $1.67 Million
Q4 2020

Mar 22, 2023

SELL
$15.77 - $19.03 $67,148 - $81,029
-4,258 Reduced 4.16%
98,169 $1.67 Million
Q4 2020

Feb 16, 2021

SELL
$15.77 - $19.03 $67,148 - $81,029
-4,258 Reduced 4.16%
98,169 $1.67 Million
Q3 2020

May 24, 2024

SELL
$16.59 - $24.79 $54,282 - $81,112
-3,272 Reduced 3.1%
102,427 $1.7 Billion
Q3 2020

Jun 26, 2023

BUY
$16.59 - $24.79 $689,795 - $1.03 Million
41,579 Added 68.33%
102,427 $1.7 Million
Q3 2020

Mar 22, 2023

SELL
$16.59 - $24.79 $54,282 - $81,112
-3,272 Reduced 3.1%
102,427 $1.7 Million
Q3 2020

Nov 13, 2020

SELL
$16.59 - $24.79 $54,282 - $81,112
-3,272 Reduced 3.1%
102,427 $1.7 Million
Q2 2020

May 24, 2024

BUY
$16.86 - $23.44 $1.78 Million - $2.48 Million
105,699 New
105,699 $2.45 Billion
Q2 2020

Jun 26, 2023

BUY
$16.86 - $23.44 $756,187 - $1.05 Million
44,851 Added 73.71%
105,699 $2.45 Million
Q2 2020

Mar 22, 2023

BUY
$16.86 - $23.44 $79,545 - $110,589
4,718 Added 4.67%
105,699 $2.45 Million
Q2 2020

Aug 14, 2020

BUY
$16.86 - $23.44 $79,545 - $110,589
4,718 Added 4.67%
105,699 $2.45 Million
Q1 2020

Jul 12, 2023

BUY
$14.47 - $27.96 $580,724 - $1.12 Million
40,133 Added 65.96%
100,981 $1.8 Million
Q4 2019

Jul 12, 2023

BUY
$15.87 - $23.12 $636,910 - $927,874
40,133 Added 65.96%
100,981 $2.18 Million
Q4 2019

Mar 22, 2023

BUY
$15.87 - $23.12 $845,601 - $1.23 Million
53,283 Added 111.71%
100,981 $2.18 Million
Q4 2019

Feb 14, 2020

BUY
$15.87 - $23.12 $845,601 - $1.23 Million
53,283 Added 111.71%
100,981 $2.18 Million
Q3 2019

Jul 12, 2023

SELL
$16.91 - $36.27 $222,366 - $476,950
-13,150 Reduced 21.61%
47,698 $869,000
Q3 2019

Mar 22, 2023

SELL
$16.91 - $36.27 $5,867 - $12,585
-347 Reduced 0.72%
47,698 $869,000
Q3 2019

Nov 14, 2019

SELL
$16.91 - $36.27 $5,867 - $12,585
-347 Reduced 0.72%
47,698 $869,000
Q2 2019

Jul 12, 2023

SELL
$31.0 - $36.3 $396,893 - $464,748
-12,803 Reduced 21.04%
48,045 $1.71 Million
Q2 2019

Mar 22, 2023

SELL
$31.0 - $36.3 $44,020 - $51,545
-1,420 Reduced 2.87%
48,045 $1.71 Million
Q2 2019

Aug 14, 2019

SELL
$31.0 - $36.3 $44,020 - $51,545
-1,420 Reduced 2.87%
48,045 $1.71 Million
Q1 2019

Jul 13, 2023

SELL
$31.58 - $46.35 $359,475 - $527,602
-11,383 Reduced 18.71%
49,465 $1.66 Million
Q1 2019

Mar 22, 2023

SELL
$31.58 - $46.35 $315 - $463
-10 Reduced 0.02%
49,465 $1.66 Million
Q1 2019

May 15, 2019

SELL
$31.58 - $46.35 $315 - $463
-10 Reduced 0.02%
49,465 $1.66 Million
Q4 2018

Jul 13, 2023

SELL
$30.43 - $56.65 $346,080 - $644,280
-11,373 Reduced 18.69%
49,475 $1.63 Million
Q4 2018

Mar 22, 2023

SELL
$30.43 - $56.65 $20,479 - $38,125
-673 Reduced 1.34%
49,475 $1.63 Million
Q4 2018

Feb 14, 2019

SELL
$30.43 - $56.65 $20,479 - $38,125
-673 Reduced 1.34%
49,475 $1.63 Million
Q3 2018

Jul 13, 2023

SELL
$46.46 - $68.49 $497,122 - $732,843
-10,700 Reduced 17.58%
50,148 $3.06 Million
Q3 2018

Mar 22, 2023

SELL
$46.46 - $68.49 $2.09 Million - $3.07 Million
-44,896 Reduced 47.24%
50,148 $3.06 Million
Q3 2018

Nov 14, 2018

BUY
$46.46 - $68.49 $126,324 - $186,224
2,719 Added 5.73%
50,148 $3.06 Million
Q2 2018

Aug 15, 2018

SELL
$46.25 - $104.45 $3.14 Million - $7.1 Million
-67,956 Reduced 58.9%
47,429 $2.32 Million
Q1 2018

May 15, 2018

BUY
$57.4 - $108.44 $2.78 Million - $5.25 Million
48,428 Added 72.33%
115,385 $12.3 Million
Q4 2017

Feb 15, 2018

BUY
$23.02 - $60.5 $1.54 Million - $4.05 Million
66,957
66,957 $4 Million

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $244M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.